Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2010-019986-27-IT
EUCTR2010-019986-27-IT
Active, not recruiting
Not Applicable

Breathing disorders in heart failure: high altitude hypoxia as a model to define diagnostic tools, therapeutic strategies and gender related differences. - ND

ISTITUTO AUXOLOGICO ITALIANO0 sitesJune 17, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsChronic heart failureMedDRA version: 9.1Level: HLGTClassification code 10019280

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic heart failure
Sponsor
ISTITUTO AUXOLOGICO ITALIANO
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 17, 2010
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\- Written informed consent \- Patients with symptomatic CHF (NYHA functional class II\-III, eitheridiopathic or ischaemic and systolic dysfunction (FE \< o \= 35%) \- Clinically stable condition for \> o \= 3 months \- Optimized CHF pharmacological treatment (all drug classes recommended by recent guidelines for this kind of patients, beta\-blockers in particular) and resynchronization therapy whenever needed with preserved spontaneous atrial activity and A\-V conduction
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •\- Atrial fibrillation \- Non optimized pharmacological treatment \- Unstable angina \- MI, cerebrovascular accident or TIA within the previous three months \- Episode of HF decompensation within the previous three months \- haemodynamic instability \- Conventional indication for pace\-maker therapy for AV blocks higher than 1st degree \- Clinically relevant pulmonary disease (FEV1\<50%, VC\<50%, FEV1/FVC\<70%) \- Inability to perform exercise test, CPAP or oxygen therapy \- Use of sedatives, acetazolamide, theophilline and aminophilline

Outcomes

Primary Outcomes

Not specified

Similar Trials

Withdrawn
Not Applicable
Understanding the Mechanisms of Diastolic DysfunctionHeart Failure With Preserved Ejection FractionHealthy
NCT03340233University of California, Los Angeles
Completed
Not Applicable
Effects of Rehabilitation in Patients With Stable Chronic Heart FailureHeart FailureAerobic ExerciseQuality of LifeRespiratory Muscle TrainingStrength TrainingExercise IntoleranceCardiac Rehabilitation
NCT03538249Lebanese University60
Completed
Not Applicable
Cardiac dysfunction and undiagnosed heart failure in women as a long term effect of the treatment of breast cancer in an unselected primary care settingcardiac dysfunctionheart failure1008220610018865
NL-OMON39592niversitair Medisch Centrum Groningen700
Completed
Not Applicable
Evaluation of Breathing, Sleep and the Effects of Continuous Positive Airway Pressure During Wakefulness in Children With Heart FailureHeart Failure
NCT02414126Assistance Publique - Hôpitaux de Paris30
Completed
Not Applicable
Do sleep studies improve outcomes for patients with respiratory failure who need to use long-term non-invasive ventilation?
ACTRN12613001372774Institute for Breathing and Sleep60